Diftovac lyofilizát a riedidlo na suspenziu pre holuby
Diftovac lyofilizát a riedidlo na suspenziu pre holuby
Authorised
- Pigeonpox virus, strain NJ, Live
Product identification
Medicine name:
Diftovac lyofilizát a riedidlo na suspenziu pre holuby
Active substance:
- Pigeonpox virus, strain NJ, Live
Target species:
-
Pigeon
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Pigeonpox virus, strain NJ, Live4.00/log 10 50% embryo infective dose0.20millilitre(s)
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Pigeon
-
All relevant tissues0dayzero days
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01ED01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Slovakia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Pharmagal Bio spol. s r.o.
Marketing authorisation date:
Manufacturing sites for batch release:
- Pharmagal Bio spol. s r.o.
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
- 97/022/11-S
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 17/12/2021